Veristat LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Veristat LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014206
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers clinical monitoring, clinical project management, data management, CDISC implementation, biostatistics, medical writing, project management, regulatory submissions-FDA representation, and statistical and strategic consulting services. It helps its clients design, execute, analyze, standardize, and report clinical studies. Veristat supports study phases in all therapeutic areas for every type of medical product. It caters to organization which develop biological products, diagnostics agents, vaccines, medical devices, immune therapies and gene therapies. Veristat is headquartered in Southborough, Massachusetts, the US.

Veristat LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Veristat LLC, Medical Devices Deals, 2011 to YTD 2017 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Veristat LLC, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Partnerships 12
Veristat Enters into Partnership with Cidara Therapeutics 12
Veristat Extends Partnership with EndoCeutics 13
Molecular Templates Enters into Agreement with Veristat 14
Veristat Enters into Agreement with Karyopharm Therapeutics 15
Veristat Partners with Multi-Regional Clinical Trials Center 16
Certara Partners with Veristat 17
Acquisition 18
Veristat Acquires Spero Oncology 18
Veristat LLC – Key Competitors 19
Veristat LLC – Key Employees 20
Veristat LLC – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Nov 07, 2016: Veristat Appoints James Roach, MD as Chief Medical Officer 22
Other Significant Developments 23
Sep 19, 2016: Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals by Establishing a Preferred Provider Agreement 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Veristat LLC, Pharmaceuticals & Healthcare, Key Facts 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Veristat LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Veristat LLC, Medical Devices Deals, 2011 to YTD 2017 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Veristat Enters into Partnership with Cidara Therapeutics 12
Veristat Extends Partnership with EndoCeutics 13
Molecular Templates Enters into Agreement with Veristat 14
Veristat Enters into Agreement with Karyopharm Therapeutics 15
Veristat Partners with Multi-Regional Clinical Trials Center 16
Certara Partners with Veristat 17
Veristat Acquires Spero Oncology 18
Veristat LLC, Key Competitors 19
Veristat LLC, Key Employees 20
Veristat LLC, Other Locations 21

★海外企業調査レポート[Veristat LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mazda Motor Corporation:企業の戦略・SWOT・財務分析
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務分析
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Enerjisa Enerji Uretim AS-エネルギー分野:企業M&A・提携分析
    Summary Enerjisa Enerji Uretim A.S. (Enerjisa Enerji), a subsidiary of Enerjisa Enerji A.S, is an energy utility. The company generates electricity from wind, lignite coal, hydro, and natural gas sources. It owns and operates wind plants such as Canakkale in Mahmudiye, Dagpazari in Mut, and Balikesi …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kao Corp (4452):企業の財務・戦略的SWOT分析
    Kao Corp (4452) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Allgeier SE (AEIN):企業の財務・戦略的SWOT分析
    Allgeier SE (AEIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Shadin Avionics LP:企業の戦略・SWOT・財務情報
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Toll Holdings Ltd:企業の戦略的SWOT分析
    Toll Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kimbell Royalty Partners LP (KRP):石油・ガス:M&Aディール及び事業提携情報
    Summary Kimbell Royalty Partners LP (KRP), is an oil and gas company that owns and acquires mineral and royalty interests in oil and natural gas properties throughout the US. The company has interests in the Permian Basin, Eagle Ford, Bakken Shale, San Juan Basin, Mid-Continent, East Texas, Barnett …
  • Lanco Infratech Ltd:企業の戦略的SWOT分析
    Lanco Infratech Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Florida Keys Electric Cooperative Association Inc:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Compal Electronics Inc (2324):企業の財務・戦略的SWOT分析
    Summary Compal Electronics Inc (Compal) is a manufacturer of notebook based personal computers, liquid crystal display (LCD) products and smart devices. The company offers products which include display, communication, ODM and OEM, digital media, smart devices and automotive electronics. It also off …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Companhia Energetica de Minas Gerais SA (CMIG4):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Minas Gerais SA (CEMIG) is an integrated energy utility. Through its subsidiaries and jointly-controlled investees, the company has presence in the electricity vertical. The company produces power from biomass, wind, solar, hydro, fossil, and nuclear sources; and proc …
  • Cleco Corporate Holdings, LLC:企業の戦略・SWOT・財務情報
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Torrent Power Limited:企業の戦略・SWOT・財務情報
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Biosceptre International Ltd-医療機器分野:企業M&A・提携分析
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Biosceptre’s diagnostic products are …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務分析
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • TBG Diagnostics Ltd (TDL):医療機器:M&Aディール及び事業提携情報
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆